Efficacy and Safety of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy and safety of tocilizumab vs placebo, in
combination with stable, ongoing therapy, with regard to reduction in signs and symptoms in
patients with moderate to severe active RA and inadequate response to current DMARD treatment